37 related articles for article (PubMed ID: 24111476)
1. Using Natural Language Processing to Measure and Improve Quality of Diabetes Care: A Systematic Review.
Turchin A; Florez Builes LF
J Diabetes Sci Technol; 2021 May; 15(3):553-560. PubMed ID: 33736486
[TBL] [Abstract][Full Text] [Related]
2. A novel data-mining approach leveraging social media to monitor consumer opinion of sitagliptin.
Akay A; Dragomir A; Erlandsson BE
IEEE J Biomed Health Inform; 2015 Jan; 19(1):389-96. PubMed ID: 25561458
[TBL] [Abstract][Full Text] [Related]
3. Network-based modeling and intelligent data mining of social media for improving care.
Akay A; Dragomir A; Erlandsson BE
IEEE J Biomed Health Inform; 2015 Jan; 19(1):210-8. PubMed ID: 25029520
[TBL] [Abstract][Full Text] [Related]
4. [Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].
Scheen AJ; Van Gaal LF
Rev Med Liege; 2008 Feb; 63(2):105-9. PubMed ID: 18372550
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of glibenclamide and sitagliptin therapy in adult patients with KCNJ11 permanent diabetes.
Sastre J; Luque A; del Val F; Aragonés A; López J
Diabetes Care; 2014; 37(3):e55-6. PubMed ID: 24558086
[No Abstract] [Full Text] [Related]
6. Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant.
Soliman AR; Fathy A; Khashab S; Shaheen N; Soliman MA
Exp Clin Transplant; 2013 Dec; 11(6):494-8. PubMed ID: 24344941
[TBL] [Abstract][Full Text] [Related]
7. A novel data-mining platform leveraging social media to monitor outcomes of Januvia.
Akay A; Dragomir A; Erlandsson BE
Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():7484-7. PubMed ID: 24111476
[TBL] [Abstract][Full Text] [Related]
8. [Incretin related agents for treatment of diabetes mellitus].
Miyagawa J; Miuchi M; Nanba M
Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):809-16. PubMed ID: 19472544
[No Abstract] [Full Text] [Related]
9. Janumet: a combination product suitable for use in patients with Type 2 diabetes.
Reynolds JK; Neumiller JJ; Campbell RK
Expert Opin Investig Drugs; 2008 Oct; 17(10):1559-65. PubMed ID: 18808315
[TBL] [Abstract][Full Text] [Related]
10. [Incretin strategy in the treatment of type 2 diabetes mellitus--the DPP-IV inhibitor sitagliptin].
Perusicová J
Vnitr Lek; 2007 Oct; 53(10):1109-13. PubMed ID: 18072437
[TBL] [Abstract][Full Text] [Related]
11. Sitagliptin: a review of its use in the management of type 2 diabetes mellitus.
Dhillon S
Drugs; 2010 Mar; 70(4):489-512. PubMed ID: 20205490
[TBL] [Abstract][Full Text] [Related]
12. New treatments for type 2 diabetes mellitus: combined therapy with sitagliptin.
Gagliardino JJ; Santoro S; Arellano S; Di Girolamo G
Expert Opin Pharmacother; 2008 Jun; 9(9):1495-507. PubMed ID: 18518780
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
